Millennium Management’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
ACM
AIC
Millennium Management's ABEO Position: Q3 2026 in Review
Millennium Management reduced its Abeona Therapeutics (ABEO) stake by 22% in Q3 2026, selling an estimated $295K and leaving 163,890 shares worth $860K. The position accounts for ﹤0.01% of the portfolio, ranked #4592.
Millennium Management first reported a position in ABEO in Q1 2015 and has held it in 42 quarters since. The position peaked at $16.5M in Q2 2019. 116 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.
- Millennium Management held 163,890 shares of Abeona Therapeutics worth $860K as of Q3 2026.
- Millennium Management sold 47,445 Abeona Therapeutics shares in Q3 2026, an estimated $295K.
- Abeona Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #4592 holding.
- Millennium Management first reported a position in Abeona Therapeutics in Q1 2015 and has held it in 42 quarters since.
- Millennium Management's Abeona Therapeutics position peaked at $16.5M in Q2 2019.
- 116 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.